BMJ 2002;325:232-233 ( 3 August )

Editorials

Prevention and cure of type 2 diabetes

Weight loss is the key to controlling the diabetes epidemic

The Department of Health has published the first part of the national service framework defining standards of care for people with diabetes. The substance---how these standards will be achieved---is now awaited. Type 2 diabetes, however, is reaching epidemic proportions, and epidemics are seldom controlled unless their causes are addressed. Obesity is strongly and causally linked to type 2 diabetes. Recent data suggest that the prevention of diabetes is feasible if weight management is addressed adequately in individuals at high risk. More controversially, weight management also has the potential to make a significant impact in those with established type 2 diabetes.

The most common definition of obesity is a body mass index greater than 30 kg/m2. In the nurses' health study the risk of type 2 diabetes in women with an index of 29-31 was 28-fold increased compared with women with an index lower than 22, and an index greater than 35 carried a 93-fold increased risk.1

The overall prevalence of self reported diabetes in the United States has reached 7.3%, and 15% in people over 60 years of age, driven by epidemic obesity.2 There is no room for complacency in the United Kingdom. The prevalence of known and new type 2 diabetes, detected by oral glucose tolerance test, was 20% in Europeans, 22% in Afro-Caribbeans, and 33% in Pakistanis in urban Manchester.3 Obesity and physical inactivity were the principal factors associated with diabetes, and waist circumference, a measure of intra-abdominal fat, was the strongest predictor of glucose tolerance. Similarly, obesity related diabetes in childhood, already common worldwide, has now reached the United Kingdom.4

So, could we prevent type 2 diabetes? In a prospective study of 84 941 female nurses followed for 16 years, a combination of five modifiable risk factors related to dietary behaviour, physical activity, weight, and cigarette smoking was identified that was associated with a remarkable 91% reduction in the risk of developing diabetes.5 Even with a family history of diabetes the risk reduction was 88%. In theory, therefore, most diabetes could be preventable, largely irrespective of genetic background.

Two pioneering studies show that this is feasible. In the Finnish diabetes prevention study weight loss in overweight subjects with impaired glucose tolerance, averaging just 3-4 kg over 4 years, led to a 58% reduction in incident diabetes.6 A similar result was achieved by the diabetes prevention programme in the United States, in which lifestyle intervention involving exercise and dietary change in subjects with impaired glucose tolerance reduced incident diabetes by 58%.7

The mechanism of prevention of diabetes probably entails changes in both dietary behaviour and physical activity, for which weight loss is a surrogate indicator. Whatever the mechanism the message is that much could be done to prevent diabetes in individuals at high risk. If theory is to be put into practice in the United Kingdom, however, where few general practitioners see a role for primary care in the prevention of diabetes,8 a substantially increased awareness of risk factors such as obesity and impaired glucose tolerance is needed. A bigger obstacle still is that lifestyle and body weight are far from being under voluntary control, and so prevention of diabetes requires sustained cultural change.

The success of the diabetes prevention studies begs a controversial question: should we put greater emphasis on weight loss for patients with new diabetes? The traditional dogma (not strongly evidence based) is that people with diabetes cannot lose weight and so this is futile. However, the regular support of a dietitian, practical help with physical activity, and behavioural change at home and at work---the central tenets of successful weight management---are absent from diabetes care. The most thought provoking data on improved glycaemic control, and sometimes remission of diabetes, through restriction of calories come from morbidly obese individuals undergoing bariatric surgery.9 Although this remedy can hardly be advocated widely, the data show how diabetes can be controlled and sometimes cured by major reductions in caloric intake. Weight loss, therefore, of at least 5-10% would be a logical goal, alongside standard glycaemic and cardiovascular targets, for many overweight people with diabetes. This would slow progression, reduce insulin requirements, allow withdrawal of treatment for some, and, most importantly, reduce mortality.10 Experience shows, however, that this is often beyond the reach of older patients; it may be more realistic for younger newly diagnosed patients, given appropriate support, and perhaps judicious use of anti-obesity drugs. Much remains to be learned about the treatment of this disease.

Testing times lie ahead for this national service framework. Epidemic type 2 diabetes demands more than a reiteration of the established glycaemic and cardiovascular targets on a grand scale. While the goal of a cure for type 2 diabetes remains some way off for most patients, prevention of diabetes and slowing of the natural history of the disease are clearly feasible. We should act on this important new evidence.

Jonathan Pinkney, senior lecturer

University Department of Medicine, Diabetes and Endocrinology Research Group, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL jpinkney{at}liverpool.ac.uk



1. Colditz G, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-513[Abstract/Free Full Text].
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-2000[Abstract/Free Full Text].
3. Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? Diabetes Care 2001; 24: 1377-1383[Abstract/Free Full Text].
4. Drake AJ, Smith A, Betts PR, Crowne EC, Shield J. Type 2 diabetes in obese white children. Arch Dis Child 2002; 86: 207-208[Abstract/Free Full Text].
5. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifetyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797[Abstract/Free Full Text].
6. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350[Abstract/Free Full Text].
7. Diabetes Prevention Program Research Group. Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403[Abstract/Free Full Text].
8. Wylie G, Hungin APS, Neely J. Impaired glucose tolerance; qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ 2002; 324: 1190-1196[Abstract/Free Full Text].
9. Pinkney JH, Sjostrom CD, Gale EAM. Should surgeons treat diabetes in severely obese people? Lancet 2001; 357: 1357-1359[CrossRef][ISI][Medline].
10. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990; 7: 228-233[ISI][Medline].


© BMJ 2002

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Prevention and cure of type 2 diabetes
Azeem Majeed, Angela Newnham, Ronan Ryan, Kamlesh Khunti, and Colin Guthrie
BMJ 2002 325: 965. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Daousi, C, Casson, I F, Gill, G V, MacFarlane, I A, Wilding, J P H, Pinkney, J H (2006). Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.. Postgrad. Med. J. 82: 280-284 [Abstract] [Full text]  
  • Christensen, N. K., Williams, P., Pfister, R. (2004). Cost Savings and Clinical Effectiveness of an Extension Service Diabetes Program. Diabetes Spectr. 17: 171-175 [Abstract] [Full text]  
  • Torgerson, J. S (2004). Review: Preventing diabetes in the obese: the XENDOS study and its context. British Journal of Diabetes & Vascular Disease 4: 22-27 [Abstract]  
  • Foliaki, S., Pearce, N. (2003). Prevention and control of diabetes in Pacific people. BMJ 327: 437-439 [Full text]  
  • Cameron, J S. (2003). Fifty years of established diabetic nephropathy -- a personal perspective. British Journal of Diabetes & Vascular Disease 3: 8-16  
  • Majeed, A., Newnham, A., Ryan, R., Khunti, K., Guthrie, C. (2002). Prevention and cure of type 2 diabetes. BMJ 325: 965-965 [Full text]  

Rapid Responses:

Read all Rapid Responses

Beyond type 2 diabetes mellitus common risk factors.
Sergio Stagnaro
bmj.com, 3 Aug 2002 [Full text]
Prevention of type 2 diabetes
Ralph L La Forge
bmj.com, 5 Aug 2002 [Full text]
Iatrogenic DM?
Göran Svensson
bmj.com, 5 Aug 2002 [Full text]
dieting cornerstone in tt of niddm
manan vasenwala
bmj.com, 6 Aug 2002 [Full text]
Upstream to Obesogenic Environments......Please !
Colin Guthrie
bmj.com, 6 Aug 2002 [Full text]
health warnings
douglas salmon
bmj.com, 8 Aug 2002 [Full text]
Involuntary obesity???
John J Kennedy
bmj.com, 25 Aug 2002 [Full text]
General practitioners are treating more cases of diabetes
Azeem Majeed, et al.
bmj.com, 28 Aug 2002 [Full text]
It´s True !
Julian A Lopez
bmj.com, 9 Sep 2002 [Full text]



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview